Cynata Therapeutics Limited (AU:CYP) has released an update.
Cynata Therapeutics Limited has announced the issuance of 1.8 million unlisted options expiring on April 17, 2029, at an exercise price of $0.29 each. These securities, part of an employee incentive scheme, are set to be issued on April 17, 2024, and will not be quoted on the ASX. This move indicates Cynata’s commitment to incentivizing their staff while potentially diluting current shareholders.
For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.
